Why Is This Treatment Important?
Data from large clinical trials suggest that antithrombotic therapy (medication to prevent blood clots) should be prescribed at discharge following acute ischemic stroke to reduce stroke mortality and morbidity as long as no contraindications exist. For patients with a stroke due to a cardioembolic source (e.g. atrial fibrillation, mechanical heart valve), warfarin is recommended unless contraindicated. Antithrombotic therapy includes taking medicines that keep the blood from clotting.
What the Scores Mean
A higher percentage is good because it means more patients received the recommended treatment. However, a lower score does not necessarily indicate poor care. You should consider the overall quality of a facility in addition to individual category scores.
About the Data
The data on this site represent the time period of October 2012 through September 2013 and are the most recent available. They are reported to the Joint Commission as a core measure set in conjunction with the Get with the Guidelines program of the American Heart Association and American Stroke Association. For more information, please visit the Joint Commission website and the American Heart Association and American Stroke Association Get with the Guidelines website.